Evidence map›Paper›PMID 22180348›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2012

Regulation of articular chondrocyte aggrecan and collagen gene expression by multiple growth factor gene transfer.

Shuiliang Shi, Scott Mercer, George J Eckert, Stephen B Trippel

Open access · hybridAbstract read
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Harnessing Growth Factor Interactions to Optimize Articular Cartilage Repair.Advances in experimental medicine and biology · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Effects of Sprifermin, IGF1, IGF2, BMP7, or CNP on Bovine Chondrocytes in Monolayer and 3D Culture.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Gene therapy for chondral and osteochondral regeneration: is the future now?Cellular and molecular life sciences : CMLS · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shuiliang ShiDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Scott Mercer
George J Eckert
Stephen B Trippel
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Gene Transfer Treatment of Articular Cartilage DamageR01AR047702 · NIAMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TRIPPEL, STEPHEN B. · 2002 to 2014
$3.8M
NIAMS NIH HHS AR047702NIAMS NIH HHS R01 AR047702
6 · The paper itself

Abstract

Gene transfer is a promising approach to the delivery of chondrotrophic growth factors to promote cartilage repair. It is unlikely that a single growth factor transgene will optimally regulate these cells. The aim of this study was to identify those growth factor transgene combinations that optimally regulate aggrecan, collagen type II and collagen type I gene expression by articular chondrocytes. We delivered combinations of the transgenes encoding fibroblast growth factor-2, insulin-like growth factor I, transforming growth factor beta1, bone morphogenetic protein-2, and/or bone morphogenetic protein-7 and assessed chondrocyte responses by measuring changes in the expression of aggrecan, type II collagen and type I collagen genes. These growth factor transgenes differentially regulated the magnitude and time course of all three-matrix protein genes. In concert, the transgenes regulated matrix gene expression in an interactive fashion that ranged from synergistic to inhibitory. Maximum stimulation of aggrecan (16-fold) and type II collagen (35-fold) expression was with the combination of IGF-I, BMP-2, and BMP-7 transgenes. The results indicate that the optimal choice of growth factor genes for cell-based cartilage repair cannot be predicted from observations of individual transgenes. Rather, such gene therapy will require an empirically based selection of growth factor gene combinations.

Indexed as

AggrecansAnimalsBone Morphogenetic Protein 2Bone Morphogenetic Protein 7Cartilage, ArticularCattleCells, CulturedChondrocytesCollagen Type ICollagen Type IIFibroblast Growth Factor 2Gene ExpressionGenetic TherapyInsulin-Like Growth Factor IIntercellular Signaling Peptides and ProteinsTransforming Growth Factor beta1AggrecansBone Morphogenetic Protein 2Bone Morphogenetic Protein 7Collagen Type ICollagen Type IIFibroblast Growth Factor 2Insulin-Like Growth Factor IIntercellular Signaling Peptides and ProteinsTransforming Growth Factor beta1

Identifiers

PMID22180348
PMCPMC4133938
OpenAlexW1987415652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.